Most Active Stories
- Shreveport fencing documentary cuts across bigger life lessons
- Northwestern State musicians perform 'Earthrise' with its British composer in the wings
- Metropolitan Opera: Mascagni’s Cavalleria Rusticana & Leoncavallo’s Pagliacci
- Elio Motors is in an 'engineering-centric' phase, says founder
- Caravan: Airheart Live in the Red River Radio studios
Glaxo To Stop Paying Doctors To Promote Drugs
Originally published on Tue December 17, 2013 11:30 pm
LINDA WERTHEIMER, HOST:
NPR's business news starts with new rules for Glaxo.
(SOUNDBITE OF MUSIC)
WERTHEIMER: The head of British - the British drug maker GlaxoSmithKline, told The New York Times yesterday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences - a practice criticized as a conflict of interest.
Glaxo's CEO told the company - told the paper - the company would also stop paying all its sales reps based on how many prescriptions doctors write. Transcript provided by NPR, Copyright NPR.